银屑病关节炎与伴银屑病强直性脊柱炎中的孤立性中轴病变
基于两个银屑病关节炎(PsA)与强直性脊柱炎(AS)队列,比较孤立性中轴型PsA、伴外周受累的中轴型PsA及伴银屑病的孤立性中轴型AS;1576例PsA中2.03%为孤立性中轴病变,HLA-B*27阳性与孤立性中轴病变相关,并预测后续外周病变发生。
要点
- 1576例PsA中孤立性中轴病变占2.03%,中轴加外周病变占29.38%。
- HLA-B*27阳性与孤立性中轴型PsA相关(OR 25.00,95%CI 3.03至206.11)。
- HLA-B*27预测孤立性中轴型PsA后续发生外周病变(HR 7.54,95%CI 1.79至31.77)。
核心结论
- 孤立性中轴型PsA与伴银屑病的孤立性中轴型AS均不常见。
- HLA-B*27阳性与孤立性中轴型PsA相关,并可能识别后续发生外周病变者。
- 孤立性中轴型PsA与较好功能状态相关,且与伴银屑病的孤立性中轴型AS在临床上似乎不同。
研究设计与样本
- 研究基于两个PsA与AS队列,识别中轴病变的PsA患者及伴银屑病的孤立性中轴型AS患者。
- 采用逻辑回归比较孤立性中轴型PsA与伴外周受累的中轴型PsA,以及伴银屑病的孤立性中轴型AS。
- 采用Cox比例风险模型评估孤立性中轴型PsA发生外周病变的预测因素。
主要发现
- 1576例PsA中,2.03%为孤立性中轴病变,29.38%为中轴加外周病变。
- HLA-B*27阳性(OR 25.00,95%CI 3.03至206.11)与较低健康评估问卷评分(OR 0.004,95%CI 0.00至0.28)与孤立性中轴病变相关。
- HLA-B*27预测随时间发生外周病变(HR 7.54,95%CI 1.79至31.77)。
- 1688例AS中,4.86%为伴银屑病的孤立性中轴病变。
- 与伴银屑病的孤立性中轴型AS相比,孤立性中轴型PsA诊断年龄更大(OR 1.06,95%CI 1.01至1.13)、更可能有甲病变(OR 12.37,95%CI 2.22至69.07)、更少可能有炎性背痛(OR 0.12,95%CI 0.02至0.61)。
关键数值与推荐
- 孤立性中轴型PsA定义及队列识别标准见原文方法部分,本文未报告具体阈值。
- HLA-B*27阳性与孤立性中轴型PsA相关(OR 25.00,95%CI 3.03至206.11)。
- 较低健康评估问卷评分与孤立性中轴型PsA相关(OR 0.004,95%CI 0.00至0.28)。
- HLA-B*27预测外周病变发生(HR 7.54,95%CI 1.79至31.77)。
- 与伴银屑病的孤立性中轴型AS相比,孤立性中轴型PsA诊断年龄OR 1.06(95%CI 1.01至1.13)、甲病变OR 12.37(95%CI 2.22至69.07)、炎性背痛OR 0.12(95%CI 0.02至0.61)。
临床怎么用
- 原文未据此给出推荐。
- 作者指出HLA-B*27阳性与孤立性中轴型PsA相关,并可能识别后续发生外周病变者。
- 作者指出孤立性中轴型PsA与较好功能状态相关,且与伴银屑病的孤立性中轴型AS在临床上似乎不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare isolated axial psoriatic arthritis (PsA), axial PsA with peripheral involvement and isolated axial ankylosing spondylitis (AS) with psoriasis. To evaluate predictors for developing peripheral disease from isolated axial PsA over time. METHODS: Two PsA and AS cohorts identified patients with PsA with axial disease and isolated axial patients with AS with psoriasis. Logistic regression compared isolated axial PsA to axial PsA with peripheral involvement and isolated axial AS with psoriasis. Cox proportional hazards model evaluated predictors for developing peripheral disease from isolated axial PsA. RESULTS: Of 1576 patients with PsA, 2.03% had isolated axial disease and 29.38% had axial and peripheral disease. human leucocyte antigen HLA-B*27 positivity (OR 25.00, 95% CI 3.03 to 206.11) and lower Health Assessment Questionnaire scores (OR 0.004, 95% CI 0.00 to 0.28) were associated with isolated axial disease. HLA-B*27 also predicted peripheral disease development over time (HR 7.54, 95% CI 1.79 to 31.77). Of 1688 patients with AS, 4.86% had isolated axial disease with psoriasis. Isolated axial patients with PsA were older at diagnosis (OR 1.06, 95% CI 1.01 to 1.13), more likely to have nail lesions (OR 12.37, 95% CI 2.22 to 69.07) and less likely to have inflammatory back pain (OR 0.12, 95% CI 0.02 to 0.61) compared with patients with isolated axial AS with psoriasis. CONCLUSIONS: Isolated axial PsA and AS with psoriasis are uncommon. HLA-B*27 positivity is associated with isolated axial PsA and may identify those who develop peripheral disease over time. Isolated axial PsA is associated with better functional status. Isolated axial PsA appears clinically distinct from isolated axial AS with psoriasis.
引用
- Kwok TSH, Sutton M, Pereira D, et al. Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis. Ann Rheum Dis. 2022. PMID: 35973805. doi:10.1136/ard-2022-222537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。